New Drug for TACTIC-E COVID-19 Trial
Pharmaceutical outsourcing specialist Quay Pharma’s acknowledged expertise in microbial…
Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial
- Phase 2/3 platform trial sponsored by Cambridge University Hospitals NHSFoundation Trust
- Experimental therapies with the potential to prevent and…
TACTIC-E trial to test whether a simple microbe could be an effective treatment for COVID-19
As part of a new trial led by Cambridge University Hospitals and supported by NIHR Cambridge Biomedical Research Centre, a microbe will be used to treat severe COVID-19 in an…
Cambridge University Hospitals group launches experimental drug trial to treat Covid-19
Cambridge University Hospitals group is launching a fast-turnaround experimental drug trial to treat Covid-19.
National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched led by clinicians and scientists in Cambridge and at King’s College London.…
National trial launched to test re-purposing existing drugs to treat COVID-19 patients
A new trial to prevent organ failure and death in COVID-19 patients has been launched led by clinicians and scientists in Cambridge and London.
Cambridge trial targets immune response to treat COVID-19 patients
A new national study, supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit will test whether two…
Trial launched testing existing drugs in bid to treat coronavirus patients
Treating Covid-19 patients may change after a nationwide trial has launched at Addenbrooke's hospital in…
Research from Cambridge to Combat COVID-19
Professor Ian Wilkinson comments on vitally important research taking place at Cambridge University Hospitals, with support of the…
New NIHR Cambridge BRC Director Appointed
The NIHR Cambridge Biomedical Research Centre (BRC) has announced Dr Miles Parkes will be the new director of the centre, based at Cambridge University Hospitals (CUH).
Findings of PEXIVAS published in the NEJM
Findings of a global trial of plasma exchange and steroid dosing in autoimmune vasculitis (PEXIVAS) have recently been …
Winter 2019 Exchange from the UKCRC Network
Featuring news from the recently held directors' meeting, operations group, results from the 2019 registration review process and much more.
Research & Development Department Newsletter: December 2019
Welcome to the final edition of the R&D Newsletter for 2019.
CCTU Launches the EudraCT Tool
The CCTU is pleased to launch the EudraCT Tool which was developed by our Lead Senior Statistician, Dr Simon Bond, in collaboration with colleagues from Birmingham, Glasgow and…
CCTU Investigator becomes chair-elect of the International Clinical Trials Centre Network (ICN)
We are pleased to announce that Dr Thomas Hiemstra has been voted in as chair-elect of the International Clinical Trials Centre Network (ICN)